Barcelona, Spain, September 30th / PRNewswire / -- Veeva Systems (New York Stock Exchange ticker: VEEV) announced today that Servier is using Veeva OpenData to standardize customer reference data in over 80 countries. Following its global success in Veeva Link Key People, this leading French pharmaceutical company, governed by a foundation, is unifying customer reference data and establishing a common foundation to expand the application of AI.
Servier World Operations Excellence Director Liam Hanrahan stated: "By centralizing our customer reference data with the help of Veeva OpenData, we are not only improving current processes but also building a globally AI ready data foundation that will redefine the way we work." He added, "The globally unified semantic layer and the connection capabilities of Veeva Link provide our subsidiaries with high-quality insights, helping us to reach the right HCP in each market, thereby enhancing efficiency and enabling us to expand AI on a global scale."
Servier indicates that with the help of OpenData and Link Key People, the company's global business and medical teams are able to utilize interconnected data, thereby gaining insights more quickly throughout the organization and taking action more swiftly.
The person in charge of Veeva Link and OpenData, President Veeva, stated: "In the industry, 89% of AI projects have not been able to expand due to data issues. By adopting standardized data prioritization AI methods across all regions, Servier has demonstrated strong industry leadership. With OpenData as the core of its unified global data foundation, Servier can achieve more effective and AI-driven business execution."
Veeva OpenData is a part of Veeva Data Cloud, which also includes Veeva Link and Veeva Compass. OpenData can unify customer reference data on a global scale, replacing fragmented data silos and promoting the consistency required for expanding advanced analytics and AI.
About Veeva Systems
Veeva provides industry cloud solutions for the life sciences sector, covering applications, agents, data, and consulting services. Veeva is committed to innovation, product excellence, and customer success, serving over 1500 clients ranging from the world's largest pharmaceutical companies to emerging biotech startups. As a public interest company, Veeva strives to balance the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, please visit veeva.com / eu.
Veeva Forward-looking Statement
This press release contains forward-looking statements regarding Veeva products and services, as well as the expected results or benefits from using such products and services. These statements are based on the company's current expectations. Actual results may differ significantly from those described in this press release, and the company has no obligation to update such statements. There are various risks and uncertainties that may have a negative impact on the company's performance, including those disclosed in the company's 10-Q filing for the fiscal year ending July 31, 2026 (a summary of these risks can be found on pages 33 to 34), as well as in subsequent filings submitted to the U.S. Securities and Exchange Commission, which can be viewed at sec.gov.
